You are here

Ireland - Candidates with presbyopia (age-related near vision loss) wanted to evaluate vision correction using corneal tissue

For this study, we recruit candidates with presbyopia (age-related near vision loss). The study evaluates the use of corneal tissue to correct near vision to eliminate the need for reading glasses or contact lenses. If you are interested to register as a candidate for this study, please complete the application form below.

Presbyopia is also known as age-related near vision loss resulting in reading issues.

People with presbyopia:  

• experience a gradual loss of the ability to focus on close objects or small print;

• typically develop problems reading up close as of the age 45; 

• find themselves struggling while reading smartphones messages, menu cards, price tags, …;

• start to hold reading material at arm’s length; 

• who don't already wear glasses or contact lenses, may choose to wear reading glasses all the time or only when necessary to magnify up-close objects. The glasses or contact lens prescription begin with plus numbers (like +2.50).

Please note, presbyopia is not the same as hyperopia. Hyperopia is not age-related. 

On 09/08/2018 the ethics committee of Beacon Hospital has given a positive advice for the conduct of this study. This approval is valid for Ireland. The study is sponsored by Allotex.


What is the goal of the clinical study?

Presbyopia can be corrected with reading glasses or contact lenses. As it might have an impact on the lifestyle, surgery might be considered to correct vision.

The objective of this clinical study is to evaluate the safety and effectiveness of implantation of the corneal tissue (allografts) for improving near vision in people with presbyopia. This correction intends to eliminate the need for correcting glasses or contact lenses.

What are corneal allografts?

Corneal allografts are precisely shaped micro-lenses which are comprised of sterile corneal tissue which has been laser processed. In this study, these tiny lenses are implanted in the cornea using a minimally invasive procedure. They are designed to change the shape of the cornea, which will adjust the point of focus of light at the back of the eye and correct the vision. Such corneal allografts work much like contact lenses. They are intended to be permanent but can be removed if without any residual concerns.

Who can participate?

To participate, candidates must meet at least the following conditions:

  • Glasses/contact lenses prescription between +1.50 and +2.50 D of reading add in the non-dominant eye.
  • Stable vision that is mostly unchanged in the prior 12 months in the non-dominant eye.
  • Discontinue wearing contact lenses at least 3 days before the evaluation and possibly as long as 2 weeks depending upon the type of contact lenses.
  • Must be willing and able to return for scheduled follow-up examinations for 24 months after surgery.

The following conditions exclude candidates from participating:

  • Participant who need also vision correction for distant vision are excluded. In other words, those already wearing glasses before they developed presbyopia cannot participate.
  • Certain underlying eye conditions that the doctor will identify during the preoperative examination. This includes cataract, keratoconus, severe dry eyes, certain retinal diseases, any prior eye surgery, a history of herpes infection of the eye, or glaucoma.
  • Pregnant, lactating, or planning to become pregnant during the course of the study.
  • Participating in any ophthalmic drug or device clinical trial during the time of this clinical investigation.

Please note that this list of conditions is not exhaustive. C-Lys selects only certain conditions and, if you respond to them, we will send you to one of the participating hospitals (you can indicate the choice of your hospital on the application form). All examinations conducted as part of the study will take place at the hospital under the supervision of a study physician.

What will happen to me if I take part?

The C-Lys team conducts the first pre-qualification step to verify if a candidate might be eligible to participate. Next, the C-Lys team refers the candidate to the study site.

At the study site:

  • Step 1:  If you may be a candidate for the study, you will be invited for a visit at the study doctor’s office. Someone at the study doctor’s office will explain the study including the risks and benefits and ask you to sign an informed consent document. The study doctor will then decide if you are eligible to participate in this study by performing an examination to determine the condition of your eyes.
  • Step 2: If eligible for the study, the corneal allograft will be transplanted to your non-dominant eye to help your near (reading) vision. This allows both eyes to be used for distance vision, while the allograft sharpens near vision in the non-dominant eye. Note that  near vision for only one eye is a often referred to as monovision.  Our procedure is an improved version and maintains good distance vison in the treated eye.

How many times will I need to visit the study site?

Your visit schedule will be as follows:

  • Evaluation Day: pre-operative evaluation takes approximately 2-3 hours
  • Day of surgery: surgery takes less than one hour
  • After the surgery:
  • After 1 Day: evaluation takes approximately 30 minutes
  • Seven follow up visits each taking approximately 2-3 hours (after 7 days and after 1/3/6/12/18/24 months)

Each appointment will include standard ophthalmic/eye procedures and you will be asked how your eye feels. You will need to tell the study staff about any problems you have had since your last visit.

Which study sites within Ireland participate in the study?

The participating study site in Ireland:

  • Wellington Eye Clinic, Dublin

What is expected from me?

Before the surgery, you will be required to:

  • discontinue wearing contact lenses at least 3 days before your evaluation and possibly as long as 2 weeks depending upon the type of contact lenses that you wear.
  • wear a contact lens in one eye (as a test or trial) to see whether you can tolerate having different vision in one eye as this is what you will have after surgery.

After the surgery, your doctor will ask you to follow a medication regimen and to take some protective measures.

What are the possible benefits and risks of taking part?

The corneal allograft may improve your near (reading) vision without glasses; however, this cannot be guaranteed. The corneal allograft is intended to be a permanent implant and will not be removed at the end of the study. If the procedure does not have the desired effect, the implants can be removed, and your vision goes back to as before.

As with any clinical study or surgery there are risks for the subject. Before you decide to take part, the study staff will explain the study and the possible risks/inconveniences. You will have the opportunity to ask questions.

Is there a compensation for participants?

The investigational product, the study visits, and the surgery are payed by the sponsor of the clinical study.

There is no financial compensation or any reimbursement of costs such as transportation.



Application form

Please complete the questions below.
(The power can be found on the arm of your glasses.)
Thank you very much, unfortunately you don’t correspond to the requested profile.

1. Privacy Policy

Version 5. This page was last modified on 25/07/2018.

This Privacy Policy is applicable to the Website and services of C-Lys. C-Lys is a trademark of the Belgian company Akcelis with enterprise number BE0634985259. By using the Website and services of C-Lys, you are deemed to have taken note of this Privacy Policy and as a result to have accepted the collection and processing of your personal data in the manner described herein. C-Lys is not responsible for the privacy policy of other websites and sources. This Privacy Policy describes both your use of the C-Lys Website ("Website") and the operation of the services provided by Akcelis under the tradename C-Lys ("C-Lys" or "us/ our/we" ). The policy describes how C-Lys collects, uses, protects and shares data. This allows you to understand exactly how we operate.

You can visit our Website without disclosing personal information. We will only obtain personal information and data from you if you: (i) register via a trial-specific application form on the Website, (ii) subscribe to the newsletter,(iii) fill out a contact form, (iv) send us an e-mail, (v) send us information by post and/or (vi) provide us with information by telephone. We will only use the personal data you provide to us for the services or purposes for which you have given your consent. C-Lys has taken steps to protect your data in accordance with the General Data Protection Regulation – Regulation (EU) 2016/679 (GDPR) and the Belgian Privacy Act (Act of 8 December 1992 on the protection of privacy with regard to the processing of personal data).

A data protection officer (DPO) has been assigned and notified to the Data Protection Authority.

1.1 Personal data

By personal data we mean any information relationg to you and provided to C-Lys when registering via a study-specific application form, via the subscription form for the newsletter, via a contact form or by telephone after initial registration on our Website.

C-Lys limits the collection of personal data to those data that are necessary to achieve the objective of their use. The retention period is never longer than the period in which the data are necessary for achieving their objective.

1.1.1 Use of your personal data
  • You sign up for a specific study and give your permission to use your personal data in the context of the pre-selection for the study: as standard practice, the data you provide on an application form for a specific clinical study are your name, first name, date of birth, gender, city, zip code, e-mail, telephone number and area of interest. In this case Akcelis acts as ‘data processor’ on behalf of the Sponsor, who is the ‘data controller’. Depending on the type of study, you may also provide additional personal information to C-Lys (such as, for example, your state of health), but C-Lys will limit the collection of personal data to those data that are necessary to achieve the objective of their use. You can provide this additional information via the application forms (study questionnaire) on our Website or during telephone contact with us or with our selected 3rd party call center. You undertake to provide us with data that is accurate, complete and up-to-date. You understand that your registration is equivalent to written consent to process your personal data, including sensitive data such as health, lifestyle and ethnic data.
    • Based on the information you provide through the application form we will determine whether you meet various preselection criteria for the specific study. In case a telephone preselection step is included in the preselection process, your personal data will be passed to our selected 3rd party call center. Only if you meet the preselection criteria after online and, if applicable, telephone preselection, your personal data will be passed to the research center participating in the specific study. The research center may contact you to discuss the study further. C-Lys may also make an appointment for you with the research center. Sharing your personal data with a participating research center does not mean that you are also effectively included in the study. The latter is outside the competence and services of C-Lys and the research center will discuss this with you in detail after further evaluation by them. Before effectively taking part in a clinical study, you must also sign a separate informed consent form. C-Lys is not responsible for the handling of your data by the research center. C-Lys/Akcelis is in no way responsible for the conduct of the clinical study, for the verification of the (medical) data of the potential candidates and/or for obtaining the informed consent of the candidates to take part in a clinical study. 
    • The online C-lys study questionnaire uses an automated decision-making technology in order to reduce data collection from the candidates that are ineligible for the clinical study advertised and to increase efficiency of the service C-lys provides. Answer to certain questions in the questionnaire will lead to different paths which will determine whether the candidates are eligible for the study. Those candidates that are determined to be eligible by the automated decision-making technology will be additionally assessed by C-lys in order to make sure that these candidates are indeed a match with the study. This automated decision-making is necessary for entering into a contractual relationship with the study candidate. Hence, if the candidate does not want to be a subject to automated decision-making, the candidate cannot apply for the study using C-lys service.
  • You subscribe to the newsletter:
    • Via the subscription form: as standard practice, the contact details that you provide on the subscription form are your name, first name, gender, address, e-mail, telephone number and area of interest. In this case Akcelis is the ‘data controller’. These contact details will be stored in the C-Lys database and Mailchimp so that C-Lys can send you newsletters via e-mail, post or SMS. 
    • You do this by selecting the option "I want to receive the newsletter" during registration for a particular study. If you select this option, only your contact details (name, first name, gender, address, e-mail, telephone number and area of interest) are stored in the C-Lys database and Mailchimp so that C-Lys can send you newsletters via e-mail, post or SMS. 

When registering on our Website or subscribing to the newsletter, once you indicate that you have read our Privacy Policy and understand and agree with it, you consent to the processing of such data as described here.The retention period never exceeds the period necessary for the achievement of the objective or for related statutory/regulatory requirements (such as, for example, quality control or inspection by regulatory authorities).

Following retention periods are applicable:

  • If you register for the newsletter: By accepting this privacy policy you agree that C-Lys processes, uses and stores your personal data for the time period for which you remain subscribed to the newsletter: end of calendar year of the registration + 5 years. This is to be able to send you information about future clinical studies, or to keep in touch with you in connection with other C-Lys services.
  • If you register for a specific study: By accepting this privacy policy you agree that C-Lys processes and uses your collected personal data until the end of the C-Lys recruitment period (as mentioned on the study webpage), independent if you are included in the study or not, and that during that period C-Lys will not block or delete your personal data. After the closure of the C-Lys recruitment period your personal data will be locked and archived for 15 years for documentation purposes. After this archiving period of 15 years your data will be permanently deleted.
1.1.2 Options regarding personal data

We offer a free of charge services in order to make sure you are able to exercise your rights as a data subject. You can view, change and delete all personal data you provide to us as well as object to processing of your personal data (some conditions may apply):

  • You have a right to view and change your personal data: If you wish you can request an overview of your personal data and amend this if necessary.
  • You have a right to data portability: In case you have registered for a study or for the newsletter and provided us with your personal data, you have a right to receive a copy of your personal data in a structured, commonly used and machine-readable format to transmit this data to another organization.
  • You have a right to request deletion of your personal data: You can decide at any time to delete your personal data from our database for any future use. This right might be limited by our legal obligations or need for keeping the data for archiving purposes in the scientific research.
  • You have the right to withdraw your consent for any future use of your personal data for a specific study. This right might be limited by our legal obligations or need for keeping the data for archiving purposes in the scientific research. After validation of this request your personal data will be deleted for future use from the C-Lys database
  • You have a right to unsubscribe from C-Lys newsletters to no longer be contacted by us
  • You have a right to demand restriction of processing of your data: After having received your request we will evaluate if the right is applicable. If applicable, your personal data will be deleted for future use from the C-Lys database
  • You also have a right to object to processing of your personal data: After having received your request we will evaluate if the right is applicable. If applicable, your personal data will be deleted for future use from the C-Lys database.

The above mentioned rights can be exercised by contacting us via the online contact form on our Website. After verifying your identity, we will do everything reasonably possible to comply with your request unless it will require completely unreasonable measures (e.g. would be technically or organizationally virtually impossible or extremely costly). We may refuse to process requests that are unreasonably repetitive or systematic.

Apart from the right mentioned in this section, you can also lodge a complaint about the processing of your personal data by C-Lys with a local Supervisory Authority.

1.1.3 Transfer of data to third-parties

We will not sell, share or distribute your personal data or disseminate this in any other way to third parties, unless otherwise provided in this Privacy Policy.

C-Lys may hire subcontractors to provide services on behalf of C-Lys. All subcontractors will only receive access to data for the provision of the C-Lys services, if C-Lys has hired the subcontractor in accordance with the objectives for which the data were originally collected. Use of the data for other objectives is prohibited. This is always included in a contract concluded with these subcontractors.

List of subcontractors that C-Lys might use:

  • Cloud service providers
  • Web hosting service providers
  • IT consultancy service
  • Quality assurance consultancy service
  • End-to-end encryption
  • Call center services

As part of the services that C-Lys supplies, it is possible that your data will be viewed by auditors, government inspectors and/or EMA (European Medicines Agency) inspectors, the FDA (Food and Drug Agency) and/or representatives of our customers in order to ensure that both C-Lys and its subcontractors act in accordance with applicable laws, regulations and good clinical practice (GCP).

In the event that C-Lys or Akcelis (or a part thereof) is sold or transferred at any time, the information that we hold may be a part of the assets to be transferred. In such case, this information will continue to be used in accordance with this Privacy Policy and you will be informed of this in writing or by e-mail.

We may make personal data public if we are legally obliged to do so, or if such action, at our discretion, is reasonably necessary to comply with legal processes, to respond to claims or to protect the rights of C-Lys, its customers, employees and the public.

C-Lys web pages are not intended for the medical reporting of side effects associated with the use of medical products or participation in a clinical study. Should you nevertheless provide us with information about any side effects, then we are compelled to follow up on this and/or to report this to the sponsor of the clinical study. This means that we may possibly contact you to gather more information (such as your medical history) in the context of this side effect. This information is then passed to the sponsor of the clinical study. The sponsor may also contact you directly in the context of the follow-up of the report on the medical side effects.

C-Lys is a Belgian company. Nevertheless, the data processing and/or transfer may take place to countries within or outside the European Union.  Under Article 21 of the Belgian Privacy Act and the Articles 44-47 of the General Data Protection Regulation – Regulation (EU) 2016/679 (GDPR), personal data may only be transferred to countries that ensure the same adequate level of protection and where the same or similar provisions of the GDPR are complied with. The country, duration of the transfer, storage, type of data and precise objectives are criteria which must be examined on a case by case basis. C-Lys guarantees that no transfer takes place to third countries for data processing or storage without the necessary steps being taken to comply with the protection requirements of the GDPR. 

Transfer mechanism that C-lys might use for your personal data transfers:

  • Adequacy decision by the European Commission
  • Privacy Shield certification
  • Standard Contractual Clauses provided by the European Commission
  • Your explicit consent for transfer
1.1.4 The security of your data

C-Lys will, to the extent possible, take technical, physical and organizational security measures which comply with applicable laws in the field of privacy and data security in order to guarantee a secure processing of your personal data. The risks of accidental or unauthorized destruction, accidental loss, alteration of or access by unauthorized persons, and any other unauthorized processing of your personal data are therefore reduced to a minimum. The safety and management procedures are reviewed on a regular basis in accordance with the latest technological developments. This includes recourse to an external security consultant. C-Lys stores your personal data in its database on specially protected servers in the Netherlands, which are ISO27001, ISO9001 and NEN7510 certified. ISO270001 and NEN7510 are internationally recognized standards for Information Security. ISO9001 is the international standard for quality management systems. The access to the database is only possible by special authorized persons who are engaged in the processing of the data. Appropriate procedures and security measures are taken for sharing the personal data with research centers.

We would like to also point out that you are personally responsible for the security of the computer, smartphone or tablet that you use to visit the C-Lys Website and to communicate certain details to C-Lys. Therefore it is important that you guarantee that the device you are using is properly secured and protected against malicious software (such as computer viruses) using appropriate security measures (such as up-to-date anti-virus software). If you have any reason to believe that your communication to us is no longer safe (for example, if you believe the security of your personal data that you may share with us is not reliable), we insist that you immediately notify us of this by e-mail or telephone.


1.2 Non-personal data

In general, you can visit our Website on the Internet without telling us who you are or revealing any personal information about yourself. In some cases, our web servers automatically collect certain non-personal data about you when you connect or follow a link to the Website. Examples of these non-personal data are: domain names, the type of Internet provider, the type of browser, the type of operating system you use, etc. The information collected relates to the number of visits, average time spent on the Website, pages viewed and other similar information. We use this information to analyze the use of the Website and improve its content.

1.2.1 Cookies and similar technologies

Our Website uses "cookie" technology (small text files that are placed by a web service on the hard drive of a device) or  similar technologies such as web analytics. This allows us to adapt our Website to suit your needs. For more information about how cookies and similar technologies can be managed, we recommend that you consult the documentation regarding your Internet browser. The message on the home page allows you to consent to our cookies policy. If you do not consent, you will be able to access the public pages of the Website but certain functions will be restricted or impossible.

For detailed information, please refer to our ‘cookie policy’.


1.3  Children

Our Website is oriented towards adults (such as anyone who is interested in clinical studies, healthcare providers and individuals seeking information related to C-Lys and the services we offer). We do not knowingly collect any information from or about children and request you not to use this Website if you are under 18 years old.


1.4 Providing third-person data

You are solely responsible for the information you provide on the C-Lys Website or by telephone to C-Lys personnel. By using the Website you agree only to provide data relating to yourself.

It is only possible to provide data relating to a third person on the C-Lys Website or by telephone to C-Lys personnel in the following exceptional cases:

  • If you are the legal representative of a third person (a minor or an incompetent person)
  • If you are a physician providing data of one of your patients

In both the above cases, C-Lys is not responsible for the registration of third-person data. If you provide data of a third person to C-Lys, you take full responsibility for any authorization required for the provision and transfer of data concerning a third person. In addition, you undertake to conscientiously respect the rights of this third person, including those described herein.


1.5 Changes

This Privacy Policy is in line with the use and capabilities of our Website. It is possible that we may change our Privacy Policy based on feedback from customers or potential study subjects and changes in our services. When we publish changes to our policy, we will change the date of the "last update" of our Privacy Policy. We will report significant changes on our homepage. Nevertheless, we encourage you to read our Privacy Policy periodically.


1.6 Questions and feedback

We regularly review our compliance with this Privacy Policy. If you have questions about this Privacy Policy, please contact us via the contact form of via the contact details below:

  • Our address: Beukenlaan 42A, 9051 Ghent, Belgium
  • Our telephone number: +32 468 34 60 20

Additionally, you can also contact our Data Protection Officer via dpo [at]


2. General Terms and Conditions

Version 3. This was last modified on 27/02/2017.

The C-Lys Website was developed by Xio on the instructions of the Belgian company “Akcelis" with enterprise number BE0634985259. Akcelis is responsible for the management of the C-Lys Website and is also responsible for processing the data it receives via the Website. Akcelis makes this Website and the information on this Website available under the following General Terms and Conditions.

By visiting this Website or using the information on this Website, you automatically accept these General Terms and Conditions. Please do not visit or use this Website if you do not agree with the Privacy Policy or the General Terms and Conditions of this Website.

Akcelis (hereafter referred to as C-Lys) is entitled to change or remove the information on this Website at all times without prior notice. Therefore we request that you re-read the General Terms and Conditions each time you visit our Website so that you are aware of any changes or amendments and have taken note of the most recent updated version of the General Terms and Conditions.


2.1 Copyright and Intellectual Property Rights

The contents of this Website (including trademarks, logos, drawings, data, product or company names, texts, images, etc.) are the property of C-Lys, unless explicitly stated otherwise, and are protected by copyright or other (intellectual ) property rights. The contents may only be used for personal use free of charge, provided the source is acknowledged.  Any other use, dissemination or publication, in any form whatsoever, is strictly prohibited without the prior written consent of C-Lys.


2.2  Limitation of liability

Despite the constant care and attention that C-Lys spends on the preparation, publication and updating of the information on this Website, it is possible that inaccuracies or incompleteness may occur in the information provided. While C-Lys makes every effort to keep the information as up-to-date as possible, it does not guarantee or make representations with respect to the up-to-date nature, accuracy or completeness of the information provided. C-Lys also does not guarantee the proper functioning of the Website.

Therefore it is the responsibility of visitors to the Website to check the information for accuracy and completeness. Visitors to the Website declare that they agree that visiting and use of the Website is at their own risk.

Neither C-Lys or Akcelis, nor its directors, employees or agents may be held liable in any way for the poor functioning or temporary unavailability of the Website or for any form of damage, direct or indirect, that would be caused by or due to the access to or use of the Website and its associated information.

C-Lys (Akcelis) is not liable for any loss or damage due to viruses, attacks or other technologically harmful materials that may damage your hardware, software, data or any other material that you own through your use of our Website.


2.3  Contact your family physician or medical specialist for diagnosis, therapy or medical advice

The objective of the C-Lys Website is to inform users. All information provided on the C-Lys Website is general in nature and not tailored to individuals or specific circumstances and cannot be used as a diagnosis, therapy or medical advice.

Accordingly, the Website user acknowledges that he/she has been fully informed of the fact that the information on the C-Lys Website is in no way is intended to:

  • provide medical advice
  • make a diagnosis
  • provide therapeutic advice
  • to replace the consultation, advice or recommendations of a health professional.

Personal information and advice can only be provided by a physician or competent authority.  For advice about your health, we recommend contacting your family physician or specialist physician. 


2.4 Information and data provided

In certain parts of the Website, users can provide information and data to C-Lys. The user is solely responsible for the authenticity and accuracy of the data he/she provides. C-Lys is not liable or responsible for the authenticity and accuracy of data provided by users of the Website.

If you provide information and/or data to us, you agree that C-Lys stores these data in the database and uses it. You warrant that the information and/or data, (a) does not infringe the (intellectual) property rights of third parties, and (b) is not otherwise unlawful towards third parties.

C-Lys reserves the right to abbreviate, change or remove this information at any time.

2.4.1 Prospective experimental subjects:

For the purposes of study-specific information, C-Lys uses the information obtained from sponsors (the customers of Akcelis). C-Lys therefore cannot take responsibility or offer a guarantee with regard to (but not limited to) the accuracy, completeness, quality and correctness of the advertising texts of the studies.

C-Lys facilitates the recruitment of participants for clinical studies. The services of C-Lys and Akcelis include (but are not limited to) the advertising of clinical studies, collecting contact details and other relevant personal data, an initial selection based on narrow criteria (inclusion and exclusion criteria), and the facilitating of contact between a (preselected) candidate and a participating research centre. It is beyond the competence and services of C-Lys to decide whether a candidate may and can also effectively take part in a clinical study. Any possible participation is discussed and evaluated further by a participating research centre.

Therefore, C-Lys or Akcelis is not responsible for:

  • The non-provision, inadequate provision or incorrect provision of information regarding the study by the research physician and his/her research personnel to the (prospective) experimental subject;
  • The non-provision, inadequate provision or incorrect provision of information by the (prospective) experimental subject to C-Lys and/or to the researcher;
  • The quality, number and suitability of prospective experimental subjects who are preselected by C-Lys. For more information about the process, we refer you to ‘referral policy’;
  • A decision taken by a research physician regarding whether or not to invite prospective experimental subjects for pre-screening;
  • A decision taken by a research physician regarding whether or not to include a prospective experimental subject in a study;
  • The quality of the studies and the quality of execution;
  • The qualifications and experience of the research centres and their personnel;
  • The potential benefits and risks associated with the studies themselves for the experimental subjects in a study;
  • Any personal injury resulting from participation in a study;
  • Any financial compensation of the experimental subjects for participation in a study;
  • The individual results of the experimental subjects in the studies and the overall results of the studies.


2.5  Reporting of adverse reactions

This Website is not intended for reporting adverse reactions associated with the use of medical products or participation in a clinical study. If you or someone you know experiences a side effect, please contact your family physician and/or research study site to report these side effects.


2.6   E-mail communications

C-Lys will send you an e-mail after you have registered via the study-specific application form, after you have subscribed for a newsletter via the subscription form or after you have completed the contact form on the C-Lys Website (for example, an e-mail confirming receipt of your application for a specific study). For this initial e-mail and all subsequent e-mail correspondence, C-Lys will always use the e-mail address you provided when registering or via the subscription form for the newsletter or via the contact form. When using this e-mail address, C-Lys assumes that you received the message/messages. Nevertheless, C-Lys is not responsible if you do not receive these e-mails. 


2.7   Third-party websites

The Website may contain hyperlinks or references to third-party websites or refer to them indirectly. Although these links or references are selected with the utmost care, C-Lys is not responsible for the content of these links and therefore cannot be held liable for any damage that may result, directly or indirectly, from the contents.

If you visit third-party websites this is at your own risk and without the consent of C-Lys. By using these links, you understand that the legal statement and the policy rules for the privacy of the relevant website are applicable and that these may differ than those of C-Lys.

You cannot hold C-Lys liable for any adverse consequences or any damage you may suffer as a result of (i) contacts made or contracts concluded on the basis of the hyperlinks, (ii) the use of data obtained via hyperlinks, or (iii) the consultation of the website(s) visited via the hyperlink.


2.8  Users from another jurisdiction

The services and product information provided by C-Lys via this Website are governed by the rules of Belgian law, to which C-Lys (Akcelis) is subject. If you visit or make use of this Website from another jurisdiction, you must verify whether this is permitted under the laws of such country in advance. Otherwise, please refrain from any (further) access to or use of the Website.


2.9  Applicable law and jurisdiction

Belgian law is applicable to this Website. In the event of a dispute, the courts of the district of Ghent in Belgium have sole jurisdiction.


  • Your personal information remains confidential. For more information we refer to the privacy policy.
  • Your registration does not mean that you will actually participate in a clinical study. More information can be found in our referral policy.
  • You have the right to view, modify or delete any personal data you have provided us. You can submit your request via the online contact form.
Forward trialI'm interested, sign me up